Literature DB >> 17041210

Nonsegmented negative-strand viruses as vaccine vectors.

Alexander Bukreyev1, Mario H Skiadopoulos, Brian R Murphy, Peter L Collins.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17041210      PMCID： PMC1641758          DOI： 10.1128/JVI.00919-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  133 in total

1.  Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.

Authors:  M H Skiadopoulos; S R Surman; A P Durbin; P L Collins; B R Murphy
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

2.  Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector.

Authors:  A A Haller; T Miller; M Mitiku; K Coelingh
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.

Authors:  Quynh N Pham; Stéphane Biacchesi; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus.

Authors:  G W Wertz; V P Perepelitsa; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.

Authors:  Sunee Techaarpornkul; Peter L Collins; Mark E Peeples
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

6.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Authors:  L S Wyatt; B Moss; S Rozenblatt
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

7.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

8.  Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.

Authors:  Alexander C Schmidt; Daniel R Wenzke; Josephine M McAuliffe; Marisa St Claire; William R Elkins; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts.

Authors:  M H Skiadopoulos; T Tao; S R Surman; P L Collins; B R Murphy
Journal:  Vaccine       Date:  1999-10-14       Impact factor: 3.641

10.  Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees.

Authors:  Mario H Skiadopoulos; Sonja R Surman; Jeffrey M Riggs; William R Elkins; Marisa St Claire; Machiko Nishio; Dominique Garcin; Daniel Kolakofsky; Peter L Collins; Brian R Murphy
Journal:  Virology       Date:  2002-05-25       Impact factor: 3.616
View more
  59 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.

Authors:  Anzhong Li; Miaoge Xue; Zayed Attia; Jingyou Yu; Mijia Lu; Chao Shan; Xueya Liang; Thomas Z Gao; Pei-Yong Shi; Mark E Peeples; Prosper N Boyaka; Shan-Lu Liu; Jianrong Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  Caution about Newcastle disease virus-based live attenuated vaccine.

Authors:  Guan-Zhu Han; Xi-Ping Liu; Si-Shen Li
Journal:  J Virol       Date:  2008-07       Impact factor: 5.103

Review 4.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

5.  What are the risks--hypothetical and observed--of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?

Authors:  Peter L Collins; Alexander Bukreyev; Brian R Murphy
Journal:  J Virol       Date:  2008-10       Impact factor: 5.103

6.  A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.

Authors:  Rohan Keshwara; Katie R Hagen; Tiago Abreu-Mota; Amy B Papaneri; David Liu; Christoph Wirblich; Reed F Johnson; Matthias J Schnell
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

7.  Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.

Authors:  Lauro Velazquez-Salinas; Shruthi Naik; Steven J Pauszek; Kah-Whye Peng; Stephen J Russell; Luis L Rodriguez
Journal:  Hum Gene Ther Clin Dev       Date:  2017-06       Impact factor: 5.032

8.  Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein.

Authors:  Shin-Hee Kim; Siba K Samal
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

9.  Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.

Authors:  Andrea M Murphy; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

10.  Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans.

Authors:  Joshua M DiNapoli; Jerrold M Ward; Lily Cheng; Lijuan Yang; Subbiah Elankumaran; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  Vaccine       Date:  2009-01-23       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.